Shanghai Leadingtac Pharmaceutical Co., Ltd.
PrivateLast Round
Series B
Dec 18, 2025
Total Funding Raised
$42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shanghai Leadingtac Pharmaceutical Co., Ltd. is a biotechnology company that develops small-molecule innovative drugs focused on targeted protein degradation for the treatment of autoimmunity and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Shanghai Leadingtac Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 18, 2025 | ||||
| Series A | Nov 18, 2024 | ||||
| Pre Seed | Nov 8, 2021 | ||||
| Angel | Nov 1, 2019 |
Shanghai Leadingtac Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Kangcheng Investment Management Co., Ltd. | Series B |
| YuanBio Venture Capital | Pre Seed |
| Lapam Capital | Series B, Series A |
| Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. | Series A |
| 湖南天瑞丰年私募股权基金管理有限公司 | Series A |
| CDH VGC | Series B |
| Hankang Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 1074% MoM.
- Jan 6, 2026
Monthly visitors increased 230% MoM.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Leadingtac Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.